Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.

Source:http://linkedlifedata.com/resource/pubmed/id/19863514

Download in:

View as

General Info

PMID
19863514